BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• 

  FDA

  Lilly, Innovent Cancer Drug Not Likely to Enjoy Regulatory Flexibility

  It’s not likely that the FDA will give the cancer drug sintilimab immediate attention, since the research was conducted exclusively in China.

  February 9, 2022

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Pharm Country

  COVID-19 Update: Therapeutic Hits and Misses and an Effective Nasal Spray

  The COVID-19 pandemic has seen a full-blown effort from biopharma and researchers to develop new drugs and test old ones against the disease, with highly mixed results.

  February 9, 2022

   · 

  4 min read

   · 

  Mark Terry
• 

  FDA

  China-Developed Drugs for U.S. Market Could Face Steep Hill

  The FDA is slowing down the process of potentially approving dozens of new medications initially developed for the Chinese market.

  February 9, 2022

   · 

  3 min read

   · 

  Alex Keown
• 

  Business

  Ventus will Aim $140 Million at Previously Undruggable Targets

  Ventus Therapeutics has raised $140 million in a Series C financing round less than two years after launching to develop therapies aimed at diseases of the innate immune system.

  February 9, 2022

   · 

  2 min read

   · 

  Alex Keown
• 

  Biotech Bay

  Deepcell Dives into Cell Morphology for a New Level of Visibility

  Deepcell, a biotechnology company spun out of Stanford University in 2017, focuses on quantifying and understanding morphology – part of the cell’s phenotype.

  February 9, 2022

   · 

  5 min read

   · 

  Maggie Chen
• 

  Biotech Beach

  Salk Scientists Reveal Therapeutic Opportunities with Sonogenetics

  In this process, scientists used ultrasonic waves—the same low-frequency waves used in medical sonograms—to activate a specific group of genetically marked cells.

  February 9, 2022

   · 

  2 min read

   · 

  Hannah Chudleigh
• 

  Drug Development

  Potential Organ-Sparing Bladder Cancer Treatment Shines in Phase II

  enGene announced positive results from its LEGEND Phase I/II clinical trial for treating high-grade NMIBC in patients with carcinoma in situ that are unresponsive to BCG treatment.

  February 9, 2022

   · 

  3 min read

   · 

  Hayley Shasteen
• 

  Pharm Country

  J&J Pauses COVID-19 Vaccine Production at Netherlands Facility

  Johnson & Johnson has temporarily paused production of its COVID-19 vaccine at its manufacturing site in The Netherlands.

  February 9, 2022

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  With $101M Launch, Seismic Seeks Place as Important Immunology Innovator

  Seismic Therapeutic, Inc. announced its launch and financing of $101 million to fund two new programs and further develop its existing IMPACT™ platform.

  February 9, 2022

   · 

  3 min read

   · 

  Claudia Beezhold
• 

  Business

  BioSpace Investigates Challenges with Compensation Disparity in the Life Sciences

  72% of employers are currently experiencing a decrease in the volume of candidates applying to their jobs.

  February 9, 2022

   · 

  6 min read

   · 

  Heather McKenzie